EGFR and non-small cell lung carcinoma: MART-1–enriched T cells (≈50% of which were MART-1 specific; data not shown) were cultured with EGFR WT (H1355) and EGFR-mutated (HCC2935, PC9) NSCLC cell lines that were HLA-A2 positive, in the presence of MART-1 peptide.